Aytu Biopharma, Inc.
AYTU
$2.39
$0.0954.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.17M | 20.40M | 20.11M | 20.01M | 19.76M |
| Total Receivables | 35.83M | 25.40M | 23.16M | 23.62M | 29.93M |
| Inventory | 11.06M | 11.09M | 11.74M | 12.63M | 13.19M |
| Prepaid Expenses | 7.46M | 6.17M | 5.73M | 5.64M | 7.25M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 1.00M |
| Total Current Assets | 72.51M | 63.05M | 60.74M | 61.89M | 71.13M |
|
|
|||||
| Total Current Assets | 72.51M | 63.05M | 60.74M | 61.89M | 71.13M |
| Net Property, Plant & Equipment | 1.66M | 1.69M | 1.92M | 1.52M | 2.76M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 48.71M | 49.96M | 51.21M | 52.45M | 54.08M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.32M | 1.52M | 1.97M | 2.23M | 889.00K |
| Total Assets | 124.20M | 116.23M | 115.83M | 118.10M | 128.86M |
|
|
|||||
| Total Accounts Payable | 12.04M | 11.70M | 13.51M | 10.44M | 10.48M |
| Total Accrued Expenses | 17.68M | 19.75M | 19.58M | 22.69M | 22.81M |
| Short-term Debt | 10.03M | 4.01M | 4.27M | 2.40M | 1.58M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.96M | 2.04M | 2.34M | 2.57M | 16.27M |
| Total Finance Division Other Current Liabilities | 29.00M | 26.54M | 21.55M | 24.14M | 32.55M |
| Total Other Current Liabilities | 29.00M | 26.54M | 21.55M | 24.14M | 32.55M |
| Total Current Liabilities | 70.71M | 64.05M | 61.25M | 62.23M | 83.69M |
|
|
|||||
| Total Current Liabilities | 70.71M | 64.05M | 61.25M | 62.23M | 83.69M |
| Long-Term Debt | 9.54M | 9.98M | 10.43M | 10.88M | -- |
| Short-term Debt | 10.03M | 4.01M | 4.27M | 2.40M | 1.58M |
| Capital Leases | 1.00M | 1.11M | 1.14M | 577.00K | 783.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.06M | 10.33M | 13.18M | 16.70M | 13.61M |
| Total Liabilities | 89.30M | 85.46M | 86.01M | 90.38M | 98.09M |
|
|
|||||
| Common Stock & APIC | 348.62M | 348.48M | 348.33M | 347.69M | 346.13M |
| Retained Earnings | -313.72M | -317.71M | -318.50M | -319.97M | -315.36M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 34.90M | 30.77M | 29.83M | 27.72M | 30.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 34.90M | 30.77M | 29.83M | 27.72M | 30.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 34.90M | 30.77M | 29.83M | 27.72M | 30.78M |
|
|
|||||